Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan
Y Mori, H Takeuchi, Y Tsutsumi - Therapeutic Advances in …, 2022 - journals.sagepub.com
Tardive dyskinesia (TD) is a movement disorder that can develop with the use of dopamine
receptor-blocking agents and is most commonly caused by antipsychotics. The use of …
receptor-blocking agents and is most commonly caused by antipsychotics. The use of …
[HTML][HTML] The ABCDs of treating tardive dyskinesia
JR Scarff - Current Psychiatry, 2020 - mdedge9-ma1.mdedge.com
Tardive dyskinesia (TD)—involuntary movement persisting for> 1 month—is often caused by
exposure to dopamine receptor–blocking agents such as antipsychotics. 1 The …
exposure to dopamine receptor–blocking agents such as antipsychotics. 1 The …
Tardive Dyskinesia: Prevention and Newer Management Strategies
S Vaidyanathan, SV Jaiswal - Annals of Indian Psychiatry, 2020 - journals.lww.com
Tardive dyskinesia (TD) is a condition where we have a limited understanding of the cause
and of management. The delayed-onset movements can occur due to prolonged exposure …
and of management. The delayed-onset movements can occur due to prolonged exposure …